Sua seleção (0)
Detalhe da pesquisa
1.
Optical coherence tomography: a window to the optic nerve in clinically isolated syndrome.
Brain;
142(4): 903-915, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30847470
2.
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.
Lancet;
391(10127): 1263-1273, 2018 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29576505
3.
Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial.
Ann Neurol;
84(4): 527-536, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30155979
4.
Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies.
Mult Scler;
: 1352458519888610, 2019 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31762387
5.
Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies.
Mult Scler;
: 1352458519881759, 2019 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31675266
6.
Matrix metalloproteinase 9 is decreased in natalizumab-treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathy.
Ann Neurol;
82(2): 186-195, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28681388
7.
Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study.
Mult Scler;
24(12): 1594-1604, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28870107
8.
Magnetic resonance imaging changes following natalizumab discontinuation in multiple sclerosis patients with progressive multifocal leukoencephalopathy.
Mult Scler;
: 1352458517750765, 2018 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29343163
9.
Optic nerve double inversion recovery hypersignal in patients with clinically isolated syndrome is associated with asymptomatic gadolinium-enhanced lesion.
Mult Scler;
: 1352458518815797, 2018 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30507349
10.
Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study.
Mult Scler;
: 1352458518771875, 2018 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29716436
11.
Imaging spectrum of Bing-Neel syndrome: how can a radiologist recognise this rare neurological complication of Waldenström's macroglobulinemia?
Eur Radiol;
2018 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29922935
12.
Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: Six years of case-referent surveillance.
J Autoimmun;
79: 84-90, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28190705
13.
Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?
Mult Scler;
23(4): 604-613, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27364322
14.
Bent spine syndrome as the initial symptom of late-onset Pompe disease.
Muscle Nerve;
56(1): 167-170, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27862019
15.
Altered signal intensity of active enhancing inflammatory lesions using post-contrast double inversion recovery MR sequence.
Eur Radiol;
27(2): 637-641, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27229340
16.
Asymptomatic Progressive Multifocal Leukoencephalopathy Associated with Natalizumab: Diagnostic Precision with MR Imaging.
Radiology;
278(3): 863-72, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26436861
17.
Introduction: Do we need multi-stakeholder colloquia in MS?
Mult Scler;
22(2 Suppl): 4-8, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27465611
18.
Conclusions: Calls to action for improving the life of MS patients and their families.
Mult Scler;
22(2 Suppl): 71-7, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27465617
19.
The patient's perspective: How to create awareness for improving access to care and treatment of MS patients?
Mult Scler;
22(2 Suppl): 9-17, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27465612
20.
The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?
Mult Scler;
22(2 Suppl): 18-33, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27465613